| Dr. med. C. Jaursch-Hancke |
| | |
| 1 | Merkle W, Dietz U, Jaursch-Hancke C. |
| | Investigation of diabetic men with erectile dysfunction to determine coronary flow reserve (CFR) and cardiac risk under medication with sildenafil (Viagra) Aktuelle Urol. 2004 Jun;35(3):222-7. German. PMID: 15258856 |
| 2 | Kneist W, Vetter G, Kann P, Jaursch-Hancke C, Heintz A, Hommel G, Junginger T. |
| | The choice between transperitoneal and retroperitoneal adrenalectomy. A prospective study. Chirurg. 2004 Nov;75(11):1098-103. German. PMID: 15205748 |
| 3 | Dietz U, Tries HP, Merkle W, Jaursch-Hancke C, Lambertz H. |
| | Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil Cardiovasc Diabetol. 2003 Aug 4;2(1):8. PMID: 12952551 |
| 4 | Mahnel R, Tan KH, Fahlbusch R, Volk B, Ludecke D, Nagel HG, Jaursch-Hancke C. |
| | Problems in differential diagnosis of non Langerhans cell histiocytosis with pituitary involvement: case report and review of literature. Endocr Pathol. 2002 Winter;13(4):361-8. Review. PMID: 12665654 |
| 5 | Dietz U, Tries HP, Merkle W, Jaursch-Hancke C, Lambertz H. |
| | Sildenafil does not change coronary flow reserve in diabetics with erectile dysfunction Dtsch Med Wochenschr. 2003 Jan 31;128(5):190-5. German. PMID: 12557110 |
| 6 | Reincke M, Wachenfeld C, Mora P, Thumser A, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B. |
| | p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. J Clin Endocrinol Metab. 1996 Oct;81(10):3636-8. PMID: 8855814 |
| 7 | Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B. |
| | Clonal composition of human adrenocortical neoplasms Cancer Res. 1994 Sep 15;54(18):4927-32. PMID: 7915195 |
| 8 | Steffen HM, Wambach G, Hoffmann A, Jaursch-Hancke C, Kaufmann W. |
| | Diagnosis and therapy of malignant peritoneal mesothelioma Med Klin (Munich). 1989 Oct 15;84(10):469-73. German. PMID: 2531268 |
| 9 | Reincke M, Winkelmann W, Jaursch-Hancke C, Kaulen D, Nieke J, Ollenschlager G, Allolio B. |
| | Diagnosis and therapy of asymptomatic adrenal tumors Dtsch Med Wochenschr. 1989 Jun 2;114(22):861-5. German. PMID: 2721390 |
| 10 | Allolio B, Jaursch-Hancke C, Reincke M, Arlt W, Metzler U, Winkelmann W. |
| | Treatment of metastatic adrenal carcinoma with suramin Dtsch Med Wochenschr. 1989 Mar 10;114(10):381-4. German. PMID: 2924693 |
| 11 | Reincke M, Allolio B, Jaursch-Hancke C, Kaulen D, Saeger W, Leonhard U, Gunther RW, Winkelmann W. |
| | Diagnostic problems in ectopic Cushing syndrome Med Klin (Munich). 1988 Sep 2;83(17):559-64. German. PMID: 3173260 |
| 12 | Reincke M, Allolio B, Kaulen D, Jaursch-Hancke C, Winkelmann W. |
| | The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease. Klin Wochenschr. 1988 Aug 1;66(15):686-9. PMID: 2845188 |
| 13 | Allolio B, Schulte HM, Kaulen D, Reincke M, Jaursch-Hancke C, Winkelmann W. |
| | Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome Klin Wochenschr. 1988 Apr 15;66(8):361-4. PMID: 3392892 |
| 14 | Reincke M, Allolio B, Jaursch-Hancke C, Kaulen D, Winkelmann W. |
| | Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide Dtsch Med Wochenschr. 1987 Oct 2;112(40):1532-5. German. PMID: 2820688 |
| | |
| | |
| Priv.-Doz. Dr. med. Kornelia Konz |
| | |
| 1 | Luft D, Pagallies OB, Konz K, Mann K, Renn W, Eggstein M. |
| | Differential diagnosis of neuropathic lesions in diabetic and alcoholicpatients. Clin Investig. 1994 Feb;72(3):200-5. |
| 2 | Krönert K, Kunzel M, Reutter B, Zimmermann C, Liebich HM, Luft D, Eggstein M. |
| | Urinary excretion patterns of endogenously produced alcohols in type 1 (IDDM) and type 2 (NIDDM) diabetes mellitus compared with healthy control subjects. Diabetes Res Clin Pract. 1990 Oct;10(2):161-5. |
| 3 | Krönert K, Holder K, Kuschmierz G, Mayer B, Renn W, Luft D, Eggstein M. |
| | Influence of cardiovascular diseases upon the results of the cardiovascularreflex tests in diabetic and nondiabetic subjects. Acta Diabetol Lat. 1990 Jan-Mar;27(1):1-10. |
| 4 | Krönert K, Grauer W, Gunderoth-Palmowski M, Schuler A, Zimmermann C, Heinrich R, Luft D, Eggstein M. |
| | Elevated muscle tissue oxygen tension in short-term insulin-dependent diabetes mellitus. Diabete Metab. 1989 Nov-Dec;15(6):376-80. |
| 5 | Jaschonek K, Faul C, Weisenberger H, Krönert K, Schroder H, Renn W. |
| | Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus. Thromb Haemost. 1989 Jun 30;61(3):535-6. |
| 6 | Krönert K, Gotz V, Reuland P, Luft D, Eggstein M. |
| | Gallbladder emptying in diabetic patients and control subjects assessed by real-time ultrasonography and cholescintigraphy: a methodological comparison. Ultrasound Med Biol. 1989;15(6):535-9. |
| 7 | Sauer W, Pfeffer F, Reuland P, Krönert K, Luft D, Renn W, Eggstein M. |
| | [Evaluating 2 simple procedures for ultrasound assessment of gastric emptying] Ultraschall Med. 1988 Dec;9(6):299-302. German. |
| 8 | Krönert K, Hulser J, Luft D, Stetter T, Eggstein M. |
| | Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction. J Clin Endocrinol Metab. 1987 Jun;64(6):1219-23. |
| 9 | Krönert K, Luft D, Baumann B, Muller PH, Eggstein M. |
| | Reduced intraindividual variability of repeated cardiovascular reflex tests: an additional marker of autonomic neuropathy in insulin-dependent (type I) diabetes mellitus? Acta Diabetol Lat. 1986 Oct-Dec;23(4):279-89. |
| 10 | Krönert K. |
| | [Diabetic neuropathy of the autonomic nervous system from the viewpoint of internal medicine] Internist (Berl). 1984 Oct;25(10):607-12. |
| 11 | Krönert K, Luft D, Eggstein M. |
| | [Diabetic neuropathy of the autonomic nervous system] Dtsch Med Wochenschr. 1983 May 13;108(19):749-53 |
| | |
| | |
| Prof. Dr. med. Gudrun Neises |
| | |
| 1 | Richter B, Neises G. |
| | Human' insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003816. PMID: 15674916 |
| 2 | Richter B, Neises G. |
| | Human' insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev. 2003;(3):CD003816. Review. PMID: 12917989 |
| 3 | Richter B, Neises G, Clar C. |
| | Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review. Endocrinol Metab Clin North Am. 2002 Sep;31(3):751-78. Review. PMID: 12227130 |
| 4 | Richter B, Neises G, Bergerhoff K. |
| | Human versus animal insulin in people with diabetes mellitus. A systematic review. Endocrinol Metab Clin North Am. 2002 Sep;31(3):723-49. Review. PMID: 12227129 |
| 5 | Richter B, Neises G, Clar C. |
| | Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis. Endocrinol Metab Clin North Am. 2002 Sep;31(3):699-722. PMID: 12227128 |
| 6 | Richter B, Neises G. |
| | Human' insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev. 2002;(3):CD003816. Review. PMID: 12137720 |
| 7 | Scherer A, Engelbrecht V, Neises G, May P, Balsam A, Spiekerkotter U, Wendel U, Modder U. |
| | MR imaging of bone marrow in glycogen storage disease type IB in children and young adults. AJR Am J Roentgenol. 2001 Aug;177(2):421-5. PMID: 11461874 |
| 8 | Neises G, Windeler J. |
| | [How much is "evidence-based"? An overview of the state of the art in research] Z Arztl Fortbild Qualitatssich. 2001 Feb;95(2):95-104. Review. German. PMID: 11268884 |
| 9 | Scherer A, Engelbrecht V, May P, Neises G, Wendel U, Modder U. |
| | [Signal changes of the bone marrow in MRI under long-term treatment with granulocyte colony-stimulating factors] Rofo. 2001 Feb;173(2):121-5. German. PMID: 11253083 |
| | |
| | |
| Prof. Dr. med K. Rett |
| | |
| 1 | Jacob S, Klimm HJ, Rett K, Helsberg K, Haring HU, Godicke J. |
| | Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2004 Jun;112(6):315-22. |
| 2 | Thamer C, Stumvoll M, Niess A, Tschritter O, Haap M, Becker R, Shirkavand F,Bachmann O, Rett K, Volk A, Haring H, Fritsche A. |
| | Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes. Diabetes Care. 2003 Jul;26(7):2126-32. |
| 3 | Haap M, Houdali B, Maerker E, Renn W, Machicao F, Hoffmeister HM, Haring HU, Rett K. |
| | Insulin-like effect of low-dose leptin on glucose transport in Langendorff rat hearts. Exp Clin Endocrinol Diabetes. 2003 May;111(3):139-45. |
| 4 | Overkamp D, Volk A, Maerker E, Heide PE, Wahl HG, Rett K, Haring HU. |
| | Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes. Diabetes Care. 2002 Nov;25(11):2065-73. |
| 5 | Wahl HG, Kausch C, Machicao F, Rett K, Stumvoll M, Haring HU. |
| | Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures. Diabetes. 2002 Apr;51(4):1060-5. |
| 6 | Houdali B, Nguyen V, Ammon HP, Haap M, Schechinger W, Machicao F, Rett K, Haring HU, Schleicher ED. |
| | Prolonged glucose infusion into conscious rats inhibits early steps in insulin signalling and induces translocation of GLUT4 and protein kinase C in skeletal muscle. Diabetologia. 2002 Mar;45(3):356-68. |
| 7 | Balletshofer BM, Rittig K, Volk A, Maerker E, Jacob S, Rett K, Haring H. |
| | Impaired non-esterified fatty acid suppression is associated with endothelial dysfunction in insulin resistant subjects. Horm Metab Res. 2001 Jul;33(7):428-31. |
| 8 | Balletshofer BM, Rittig K, Rett K, Haring HU, Nawroth PP. |
| | Flow associated (endothelium dependent) vasodilation and TSH-levels in young normotensive and normoglycemic subjects. Vasa. 2001 May;30(2):97-100. |
| 9 | Brechtel K, Niess AM, Machann J, Rett K, Schick F, Claussen CD, Dickhuth HH, Haering HU, Jacob S. |
| | Utilisation of intramyocellular lipids (IMCLs) during exercise as assessed by proton magnetic resonance spectroscopy (1H-MRS). Horm Metab Res. 2001 Feb;33(2):63-6. |
| 10 | Rett K. |
| | The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Diabetes Obes Metab. 1999 May;1 Suppl 1:S8-16. Review. |
| 11 | Kausch C, Krutzfeldt J, Witke A, Rettig A, Bachmann O, Rett K, Matthaei S, Machicao F, Haring HU, Stumvoll M. |
| | Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem Biophys Res Commun. 2001 Jan 26;280(3):664-74. |
| 12 | Koch M, Rett K, Volk A, Maerker E, Haist K, Weisser M, Rettig A, Renn W, Haring HU. |
| | The tumour necrosis factor alpha -238 G --> A and -308 G --> A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients. Diabetologia. 2000 Feb;43(2):181-4. |
| 13 | Hoffmann MM, Jacob S, Luft D, Schmulling RM, Rett K, Marz W, Haring HU, Matthaei S. |
| | Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis. J Clin Endocrinol Metab. 2000 Dec;85(12):4795-8. |
| 14 | Jacob S, Stumvoll M, Becker R, Koch M, Nielsen M, Loblein K, Maerker E, Volk A, Renn W, Balletshofer B, Machicao F, Rett K, Haring HU. |
| | The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Horm Metab Res. 2000 Oct;32(10):413-6. |
| 15 | Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Rettig A, Renn W, Haring HU. |
| | The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany. Exp Clin Endocrinol Diabetes. 2000;108(5):341-6. |
| 16 | Rett K. |
| | [Risk factor hyperinsulinemia? Risk predictor insulin resistance!] Dtsch Med Wochenschr. 2000 May 26;125(21):676-7. Review. |
| 17 | Krutzfeldt J, Kausch C, Volk A, Klein HH, Rett K, Haring HU, Stumvoll M. |
| | Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes. 2000 Jun;49(6):992-8. |
| 18 | Jacob S, Balletshofer B, Henriksen EJ, Volk A, Mehnert B, Loblein K, Haring HU, Rett K. |
| | Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta-blockers. Blood Press. 1999;8(5-6):261-8. Review. |
| 19 | Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Haring HU. |
| | Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000 Apr 18;101(15):1780-4. |
| 20 | Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E. |
| | Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord. 1999 Dec;23(12):1307-13. |
| 21 | Jacob S, Rett K, Henriksen EJ, Haring HU. |
| | Thioctic acid--effects on insulin sensitivity and glucose-metabolism. Biofactors. 1999;10(2-3):169-74. Review. |
| 22 | Jacob S, Hauer B, Becker R, Artzner S, Grauer P, Loblein K, Nielsen M, Renn W, Rett K, Wahl HG, Stumvoll M, Haring HU. |
| | Lipolysis in skeletal muscle is rapidly regulated by low physiological doses of insulin. Diabetologia. 1999 Oct;42(10):1171-4. |
| 23 | Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Moller W, Tritschler HJ, Mehnert H. |
| | Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res. 1999 Sep;31(3):171-9. |
| 24 | Koch M, Rett K, Volk A, Maerker E, Haist K, Deninger M, Renn W, Haring HU. |
| | Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 1999;107(5):318-22. |
| 25 | Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. |
| | Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999 Aug;27(3-4):309-14. |
| 26 | Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Haring HU. |
| | The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia. 1999 Jun;42(6):758-62. |
| 27 | Jacob S, Machann J, Rett K, Brechtel K, Volk A, Renn W, Maerker E, Matthaei S, Schick F, Claussen CD, Haring HU. |
| | Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes. 1999 May;48(5):1113-9. |
| 28 | Volk A, Renn W, Overkamp D, Mehnert B, Maerker E, Jacob S, Balletshofer B, Haring HU, Rett K. |
| | Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight. Exp Clin Endocrinol Diabetes. 1999;107(2):140-7. |
| 29 | Jacob S, Rett K, Henriksen EJ. |
| | Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? Am J Hypertens. 1998 Oct;11(10):1258-65. Review. |
| 30 | Rett K, Maerker E, Renn W, van Gilst W, Haering HU. |
| | Perfusion-independent effect of bradykinin and fosinoprilate on glucose transport in Langendorff rat hearts. Am J Cardiol. 1997 Aug 4;80(3A):143A-147A. |
| 31 | Luft D, Rett K. |
| | [Impaired glucose tolerance] Internist (Berl). 1997 Jun;38(6):610-2. |
| 32 | Kellerer M, Rett K, Renn W, Groop L, Haring HU. |
| | Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res. 1996 Dec;28(12):737-43. |
| 33 | Wicklmayr M, Rett K, Standl E. |
| | [Newly manifested type IIb diabetes presents with significant hyperinsulinemia] Med Klin. 1996 Apr 10;91(4):189-92. German. |
| 34 | Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ. |
| | Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens. 1996 Apr;14(4):489-94. |
| 35 | Rett K, Wicklmayr M, Dietze GJ, Haring HU. |
| | Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin. Diabetes. 1996 Jan;45 Suppl 1:S66-9. |
| 36 | Dietze GJ, Wicklmayr M, Rett K, Jacob S, Henriksen EJ. |
| | Potential role of bradykinin in forearm muscle metabolism in humans. Diabetes. 1996 Jan;45 Suppl 1:S110-4. Review. |
| 37 | Rett K, Wicklmayr M, Standl E. |
| | Management of the patient with type 2 diabetes. What is new? Nephrol Dial Transplant. 1995 Oct;10(10):1787-8. |
| 38 | Rett K, Wicklmayr M, Standl E. |
| | Hypertension in the non-insulin-dependent diabetes mellitus syndrome: a critical review of therapeutic intervention. J Hypertens Suppl. 1995 Aug;13(2):S81-5. Review. |
| 39 | Fliser D, Rett K, Hubinger A, Ritz E. |
| | Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure. Nephrol Dial Transplant. 1995;10(5):643-7. |
| 40 | Rett K, Wicklmayr M, Mehnert H. |
| | New aspects of insulin resistance in hypertension. Eur Heart J. 1994 Aug;15 Suppl C:78-81. Review. |
| 41 | Wicklmayr M, Rett K, Standl E. |
| | [How can primary prevention of coronary heart disease be improved in general practice?] Med Klin. 1994 Apr 15;89(4):184-6, 229. |
| 42 | Galante P, Maerker E, Scholz R, Rett K, Herberg L, Mosthaf L, Haring HU. |
| | Insulin-induced translocation of GLUT 4 in skeletal muscle of insulin-resistant Zucker rats. Diabetologia. 1994 Jan;37(1):3-9. |
| 43 | Rett K, Wicklmayr M, Standl E. |
| | [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy] Wien Klin Wochenschr. 1994;106(24):750-7. Review. |
| 44 | Rett K, Jacob S, Wicklmayr M. |
| | Possible synergistic effect of ACE inhibition and calcium-channel blockade on insulin sensitivity in insulin-resistant type II diabetic hypertensive patients. J Cardiovasc Pharmacol. 1994;23 Suppl 1:S29-33. Review. |
| 45 | Rett K, Wicklmayr M. |
| | [Metabolic syndrome. A new challenge for preventive medicine] Dtsch Med Wochenschr. 1993 Oct 1;118(39):1407-11. |
| 46 | Rett K. |
| | [Hypertension in metabolic syndrome. Etiology and consequences] Fortschr Med. 1992 Dec 10;110(34):642-4. Review. |
| 47 | Bader S, Scholz R, Kellerer M, Tippmer S, Rett K, Matthaei S, Freund P, Haring HU. |
| | Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT 4) levels in the skeletal muscle of hyperinsulinaemic hypertensive rats. Diabetologia. 1992 Aug;35(8):712-8. |
| 48 | Rett K, Wicklmayr M, Mehnert H. |
| | What is the clinical significance of insulin resistance? J Cardiovasc Pharmacol. 1992;20 Suppl 11:S22-6. Review. |
| 49 | Baldermann H, Wicklmayr M, Rett K, Banholzer P, Dietze G, Mehnert H. |
| | Changes of hepatic morphology during parenteral nutrition with lipid emulsions containing LCT or MCT/LCT quantified by ultrasound. JPEN J Parenter Enteral Nutr. 1991 Nov-Dec;15(6):601-3. |
| 50 | Rett K, Wicklmayr M, Dietze G, Mehnert H. |
| | [The misconstrued metabolic syndrome essential hypertension. Chronology of interdisciplinary change in attitude] Med Klin. 1991 Feb 15;86(2):86-91. Review. |
| 51 | Rett K, Wicklmayr M, Dietze G, Mehnert H. |
| | Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia. 1991 Feb;34(2):137-8. |
| 52 | Stiegler H, Wicklmayr M, Rett K, Mehnert H. |
| | [Effect of prostaglandin E1 on amino acid metabolism of human skeletal muscle] Klin Wochenschr. 1990 Apr 2;68(7):380-3. |
| 53 | Dietze G, Wicklmayr M, Rett K, Mehnert H. |
| | [Essential hypertension and diabetes mellitus] Fortschr Med. 1990 Feb 28;108(6):103-6. |
| 54 | Dietze GJ, Rett K, Wicklmayr M, Mehnert H. |
| | [ACE-inhibitors and glucose metabolism] Wien Med Wochenschr. 1990 Jan 31;140(1-2):35-9. |
| 55 | Rett K, Wicklmayr M, Dietze G, Mehnert H. |
| | Clinical studies with CE-inhibitors in diabetes. Horm Metab Res Suppl. 1990;22:69-74. |
| 56 | Buhler FR, Ritz E, Rett K. |
| | [Hyperinsulinemia. Current thinking on cardiovascular risks] Fortschr Med Suppl. 1990;93:3-11. |
| 57 | Tio RA, van Gilst WH, Rett K, Wolters K, Dietze GJ, Wesseling H. |
| | The effects of bradykinin and the ischemic isolated rat heart. Horm Metab Res Suppl. 1990;22:85-9. |
| 58 | Wicklmayr M, Rett K, Dietze G, Mehnert H. |
| | Effects of beta-blocking agents on insulin secretion and glucose disposal. Horm Metab Res Suppl. 1990;22:29-33. |
| 59 | Rett K, Wicklmayr M, Dietze GJ. |
| | Metabolic effects of kinins: historical and recent developments. J Cardiovasc Pharmacol. 1990;15 Suppl 6:S57-9. |
| 60 | Wicklmayr M, Rett K, Baldermann H, Dietze G, Mehnert H. |
| | [Artificial nutrition of diabetic patients] Infusionstherapie. 1989 Oct;16(5):233-6. Review. |
| 61 | Wicklmayr M, Rett K, Fink E, Tschollar W, Baldermann H, Tymiec M, Dietze G, Mehnert H. |
| | Kinins are not liberated by working skeletal muscle in the majority of patients with essential hypertension. Horm Metab Res. 1989 May;21(5):292-3. |
| 62 | Rett K, Wicklmayr M, Fink E, Maerker E, Dietze G, Mehnert H. |
| | Local generation of kinins in working skeletal muscle tissue in man. Biol Chem Hoppe Seyler. 1989 May;370(5):445-9. |
| 63 | Wicklmayr M, Rett K, Fink E, Tschollar W, Baldermann H, Tymiec M, Dietze G, Mehnert H. |
| | Bradykinin is not liberated by working skeletal muscle in diabetes type II. Horm Metab Res. 1989 Apr;21(4):222-3. |
| 64 | Wicklmayr M, Rett K, Baldermann H, Dietze G. |
| | The kallikrein/kinin system in the pathogenesis of hypertension in diabetes mellitus. Diabete Metab. 1989;15(5 Pt 2):306-10. |
| 65 | Stiegler H, Rett K, Wicklmayr M, Mehnert H. |
| | Metabolic effects of prostaglandin E1 on human skeletal muscle with special regard to the amino acid metabolism. Vasa Suppl. 1989;28:14-8. |
| 66 | Jauch KW, Gunther B, Rett K, Hartl W, Wicklmayr M, Dietze G, Fink E, Georgieff M, Neumeier D. |
| | Dose-dependent effects of bradykinin infusion in postoperative patients. Adv Exp Med Biol. 1989;247A:603-8. |
| 67 | Rett K, Jauch KW, Wicklmayr M, Fink E, Dietze GJ, Mehnert H. |
| | Increased insulin-responsiveness by ACE-inhibition in noninsulin dependent diabetes mellitus. Adv Exp Med Biol. 1989;247A:207-13. |
| 68 | Rett K, Wicklmayr M, Dietze GJ. |
| | Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril. N Engl J Med. 1988 Dec 15;319(24):1609. |
| 69 | Wicklmayr M, Rett K, Fink E, Tschollar W, Dietze G, Mehnert H. |
| | Local liberation of kinins by working skeletal muscle tissue in man. Horm Metab Res. 1988 Aug;20(8):535. |
| 70 | Rett K, Wicklmayr M, Baldermann H, Dietze G, Schwiegelshohn B, Mehnert H. |
| | Inhibition of muscular ketone extraction by lipid infusion in man. Horm Metab Res. 1988 Aug;20(8):502-5. |
| 71 | Baldermann H, Wicklmayr M, Rett K, Banholzer P, Dietze G, Mehnert H. |
| | [Changes in ultrasonic findings in the liver in relation to parenteral nutrition with long chain triglyceride and medium chain triglyceride/long chain triglyceride lipid solutions] Infusionstherapie. 1988 Aug;15(4):140-3. |
| 72 | Rett K, Wicklmayr M, Baldermann H, Schwiegelshohn B, Dietze G, Mehnert H. |
| | [Inhibition of muscle amino acid release by infusion of a triglyceride emulsion] Infusionstherapie. 1988 Apr;15(2):78-82. |
| 73 | Rett K, Lotz N, Wicklmayr M, Fink E, Jauch KW, Gunther B, Dietze G. |
| | [Improved insulin action by ACE inhibition in type-2 diabetics] Dtsch Med Wochenschr. 1988 Feb 19;113(7):243-9. |
| 74 | Rett K, Wicklmayr M, Dietze G, Mehnert H. |
| | [Plasma clearance of MCT/LCT and LCT emulsions in diabetic patients] Beitr Infusionther Klin Ernahr. 1988;20:179-88. |
| 75 | Stiegler H, Rett K, Wicklmayr M, Dietze K, Mehnert H. |
| | Metabolic effects of prostaglandin E1 on human skeletal muscle. Vasa. 1988;17(1):5-9. |
| 76 | Wicklmayr M, Rett K, Dietze G, Mehnert H. |
| | Comparison of metabolic clearance rates of MCT/LCT and LCT emulsions in diabetics. JPEN J Parenter Enteral Nutr. 1988 Jan-Feb;12(1):68-71. |
| 77 | Rett K, Wicklmayr M, Tschollar W, Dietze G, Mehnert H. |
| | Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus. Postgrad Med J. 1988;64 Suppl 3:69-74; discussion 90-2. |
| 78 | Dietze GJ, Rett K, Jauch KW, Wicklmayr M, Fink E, Hartl W, Gunther B, Fritz H, Mehnert H. |
| | [Captopril in hypertensive patients with type II diabetes mellitus] Herz. 1987 Dec;12 Suppl 1:16-21 |
| 79 | Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G. |
| | Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1987 Oct;17(5):448-54. |
| 80 | Rett K, Maerker E, Wicklmayr M, Dietze G, Mehnert H. |
| | [The method of the isolated perfused rat heart using the Langendorff model in nutrition research] Infusionsther Klin Ernahr. 1987 Aug;14(4):189-92. |
| 81 | Wicklmayr M, Rett K, Dietze G, Mehnert H. |
| | [Detection of substrate metabolism in skeletal muscles in the human] Infusionsther Klin Ernahr. 1987 Aug;14(4):164-8. |
| 82 | Wicklmayr M, Rett K, Schwiegelshohn B, Wolfram G, Hailer S, Dietze G. |
| | Inhibition of muscular amino acid release by lipid infusion in man. Eur J Clin Invest. 1987 Aug;17(4):301-5. |
| 83 | Stiegler H, Wicklmayr M, Rett K, Dietze G, Mehnert H. |
| | [Metabolic effects of prostaglandin El on human skeletal muscle] Vasa Suppl. 1987;20:192-5. |
| 84 | Wicklmayr M, Rett K, Dietze G, Mehnert H. |
| | [Comparative studies of the metabolism of MCT/LCT and LCT emulsions in diabetics] Infusionsther Klin Ernahr. 1986 Dec;13(6):287-90. |
| 85 | Wicklmayr M, Rett K, Dietze G, Mehnert H. |
| | Inhibition of muscular triglyceride lipolysis by ketone bodies: a mechanism for energy-preservation in starvation. Horm Metab Res. 1986 Jul;18(7):476-8. |
| 86 | Rett K, Wicklmayr M, Schwiegelshohn B, Mickan C, Dietze G, Mehnert H. |
| | [Effect of fructose and sorbitol on insulin-induced hypoglycemia] Dtsch Med Wochenschr. 1986 May 16;111(20):780-4. |
| 87 | Jauch KW, Gunther B, Hartl W, Rett K, Wicklmayr M, Dietze G. |
| | Improvement of impaired postoperative insulin action by bradykinin. Biol Chem Hoppe Seyler. 1986 Mar;367(3):207-10. |
| 88 | Dietze GJ, Wicklmayr M, Rett K, Gunther B, Jauch KW, Fritz H, Mehnert H, Heberer G. |
| | [Postreceptor defect in the effectiveness of insulin: significance of the kallikrein-kinin-prostaglandin system] Beitr Infusionther Klin Ernahr. 1986;16:92-102. |
| 89 | Rett K, Jauch KW, Wicklmayr M, Dietze G, Fink E, Mehnert H. |
| | Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience. Postgrad Med J. 1986;62 Suppl 1:59-64. |
| 90 | Rett K, Maerker E, Lodri C, Wicklmayr M, Dietze G. |
| | Effects of kallikrein (K), bradykinin (B) and insulin (I), on substrate metabolism in the isolated perfused rat heart. Adv Exp Med Biol. 1986;198 Pt B:379-84. |
| 91 | Wicklmayr M, Dietze G, Rett K, Mehnert H. |
| | Evidence for a substrate regulation of triglyceride lipolysis in human skeletal muscle. Horm Metab Res. 1985 Sep;17(9):471-5. |
| 92 | Wicklmayr M, Dietze G, Brunnbauer H, Rett K, Mehnert H. |
| | Dose-dependent effect of bradykinin on muscular blood flow and glucose uptake in man. Hoppe Seylers Z Physiol Chem. 1983 Jul;364(7):831-3. |
Publikationen
